A 46-year-old womanwith hypothyroid Graves' disease (EMOsyndrome) is reported. The patient had bilateral exophthalmos, conjunctival chemosis, periorbital edema and limitation of lateral gaze. Laboratory examination revealed the presence of primary hypothyroidism with positive thyroid-stimulating hormone (TSH) binding inhibitory immunoglobulin and thyroid stimulation antibody. These fiindings indicated a diagnosis ofhypothyroid Graves' disease or EMO syndrome. She received levothyroxine replacement and steroid pulse therapy followed by radiotherapy. Her visual symptomsshowed marked improvement and pretibial myxedemadisappeared. Although several studies indicate that hypothyroid Graves' disease is a different entity from hyperthyroid Graves' disease, this report suggests that steroid pulse therapy combined with radiotherapy may be effective to treat ophthalmopathy in both diseases. (Internal Medicine 32: 421-423, 1993) 
Introduction
Graves' disease is characterized by hyperthyroidism with diffuse goiter, infiltrative ophthalmopathy and pretibial myxedema (1) . A subgroup of Graves' disease presenting with hypothyroidism has been reported and is called hypothyroid Graves ' disease (2) or Exophthalmos-myxoedemacircumscriptum praetibiale-osteoarthropathia hypertrophicans (EMO) syndrome (3).
Here, we report a case ofhypothyroid Graves ' disease (EMO syndrome) which responded very well to the combined therapy with levothyroxine, steroid pulse therapy and high energy Xray irradiation to the orbit. Although there is increasing evidence suggesting that hypothyroid Graves ' disease is a different entity from "hyperthyroid" Graves ' disease, the combination of steroid pulse therapy and irradiation to the orbit may be effective in treating the ophthalmopathy of hypothyroid Graves' disease as well as "hyperthyroid" Graves' ophthalmopathy.
Case Report (TRab, Baxter, normal range less than 10%). Thyroid stimulation antibody (TSAb) and thyroid-stimulation blocking antibody (TSBAb) were assayed in FRTL-5 thyroid cells as previously described (5). The thyroid function test revealed the presence of primary hypothyroidism (free T4 0.6 ng/dl and TSH 67.3 jiU/ml). TBII and TSAb were positive (34.0% and 200%, respectively), but TSBAbwas negative. Antithyroid microsomal antibody was positive (x402), and antithyroglobulin antibody was negative. Treatment with levothyroxine (200 jig/day) was initiated. 99mTc uptake ratio (30 min) was not decreased ( 1.22%) even after the normalization of TSHlevels by replacement therapy, suggesting nonsuppressibility of the thyroid. These findings indicated a diagnosis of hypothyroid Graves ' disease (EMO syndrome).
Since the ophthalmopathy improved after administration of prednisolone (25 mg/day for 10 days), steroid pulse therapy (methylprednisolone 1,000 mg, iv for 3 days) was given, followed by radiation to the orbit with high energy X-ray (20Gy) generated by a linear accelerator, as described previously (6) ( Fig. 1) . Prednisolone was administered orally (40 mg/day for 10 days) and tapered. Visual symptoms such as lacrimation and double vision completely disappeared, which was in accordance with improvementof muscle hypertrophy on MRI. Conjunctival chemosis and preorbital edema also disappeared. Proptosis decreased to 18 mmin each eye. Therefore, the ophthalmopathy index was decreased to zero. TBII, TSAb and antithyroid microsomal antibody were also decreased to 6.3%, 108% and x202, respectively. Her pretibial myxedema disappeared. The amountoflevothyroxine required to maintain a normal TSH value decreased to 150 jag/day. The patient showed no sign or symptom suggesting recurrence of ophthalmopathy four months after steroid pulse therapy and irradiation.
Discussion
Christy and Morse (2) defined hypothyroid Graves ' disease as a subgroup of Graves' disease with ophthalmopathy and/or pretibial edema, which presents as hypothyroidism without any antithyroid treatment. It has been reported that spontaneous hypothyroidism develops in some patients with Graves ' disease who were previously treated with antithyroid drugs, and that about one-third of such patients are thought to be hypothyroid because of the presence of TSBAb (5). In contrast, in a very recent study, none of the patients with hypothyroid Graves' disease had positive TSBAb(7). These findings suggest that the pathogenesis of hypothyroid Graves ' disease may differ from that of "hyperthyroid" Graves' disease. with levothyroxine. In summary,the present case suggests that the combination of high-dose steroid and irradiation to the orbit maybe effective in the treatment of ophthalmopathy in hypothyroid Graves' disease, as well as in "hyperthyroid" Graves ' ophthalmopathy.
